These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O. Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782 [Abstract] [Full Text] [Related]
5. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC. Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264 [Abstract] [Full Text] [Related]
6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Drugs; 2006 May; 66(17):2235-54. PubMed ID: 17137405 [Abstract] [Full Text] [Related]
7. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study. Ekström T, Ringdal N, Tukiainen P, Runnerström E, Soliman S. Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798 [Abstract] [Full Text] [Related]
8. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C. Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [Abstract] [Full Text] [Related]
10. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E. Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085 [Abstract] [Full Text] [Related]
11. Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O. Eur Respir J; 2002 Oct; 20(4):859-66. PubMed ID: 12412676 [Abstract] [Full Text] [Related]
12. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. Bensch G, Berger WE, Blokhin BM, Socolovsky AL, Thomson MH, Till MD, Castellsague J, Della Cioppa G, International Study Group on Foradil Evaluation in Pediatric Asthma. Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575 [Abstract] [Full Text] [Related]
16. A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease. Vervloet D, Ekström T, Pela R, Duce Gracia F, Kopp C, Silvert BD, Quebe-Fehling E, Della Cioppa G, Di Benedetto G. Respir Med; 1998 Jun; 92(6):836-42. PubMed ID: 9850367 [Abstract] [Full Text] [Related]
18. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H. Eur Respir J; 2003 Jan; 21(1):74-81. PubMed ID: 12570112 [Abstract] [Full Text] [Related]
19. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G. Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580 [Abstract] [Full Text] [Related]